The inquiry centers on whether Epic, which operates the ubiquitous MyChart patient portal, has leveraged its market dominance to stifle competition. According to sources familiar with the matter, the FTC has issued investigative demands to various players within the health technology sector to determine if the company unfairly controls the flow of information between providers.
This federal scrutiny arrives as the privately held company already navigates legal challenges from competitors and state authorities. Both Particle Health and the state of Texas have filed lawsuits accusing Epic of intentionally blocking rivals from its ecosystem. In response to these allegations, the company maintains that its systems are interoperable and emphasizes that its healthcare provider clients, rather than the software firm itself, retain ultimate authority over who accesses specific patient records.

Comments (0)
No comments yet. Be the first!